These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17498395)

  • 1. Enhanced nuclear delivery and cytotoxic activity of hydroxycamptothecin using o/w emulsions.
    Zhao Y; Gao J; Sun X; Chen H; Wu L; Liang W
    J Pharm Pharm Sci; 2007; 10(1):61-70. PubMed ID: 17498395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
    Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
    Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsions.
    Zhao YX; Liu DX; Liang WQ; Ye ZW
    J Pharm Pharmacol; 2012 Jun; 64(6):783-91. PubMed ID: 22571256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I.
    Zhang R; Li Y; Cai Q; Liu T; Sun H; Chambless B
    Cancer Chemother Pharmacol; 1998; 41(4):257-67. PubMed ID: 9488594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
    Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
    Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
    Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
    J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified hydrolysis kinetics of the active lactone moiety of 10-hydroxycamptothecin by liposomal encapsulation.
    Shi K; Tian Y; Jiang Y; Wang L; Cui F
    Pharm Dev Technol; 2010 Dec; 15(6):644-52. PubMed ID: 19943738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
    Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
    Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effects of ring-closed and ring-opened hydroxycamptothecin on oral squamous carcinoma cell line Tca8113].
    Wang AX; Li S; Ding XQ; Chen Y; Chen D
    Ai Zheng; 2005 Aug; 24(8):970-4. PubMed ID: 16086875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.
    Yuan Y; Wen J; Tang J; Kan Q; Ackermann R; Olsen K; Schwendeman A
    Int J Nanomedicine; 2016; 11():6229-6238. PubMed ID: 27920529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of hydroxycamptothecin-loaded poly[ethylene glycol]-poly [gamma-benzyl-L-glutamate] micelles against oral squamous cell carcinoma.
    Ding XQ; Chen D; Wang AX; Li S; Chen Y; Wang J
    Oncol Res; 2007; 16(7):313-23. PubMed ID: 17518269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria and nucleus delivery of active form of 10-hydroxycamptothecin with dual shell to precisely treat colorectal cancer.
    Li HQ; Ye WL; Huan ML; Cheng Y; Liu DZ; Cui H; Liu M; Zhang BL; Mei QB; Zhou SY
    Nanomedicine (Lond); 2019 Apr; 14(8):1011-1032. PubMed ID: 30925116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
    Zhu H; Cao J; Cui S; Qian Z; Gu Y
    J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution of hydroxycamptothecin after aerosol inhalation in rabbits].
    Chen J; Fang Y; Zhang HX; Huang LL; Qian XP; Liu BR
    Yao Xue Xue Bao; 2004 Sep; 39(9):747-51. PubMed ID: 15606028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
    Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
    Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch-10-hydroxy camptothecin conjugate: synthesis, pharmacokinetics, cytotoxicity and pharmacodynamics research.
    Li G; Cai C; Qi Y; Tang X
    Drug Deliv; 2016; 23(1):277-84. PubMed ID: 24833272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between lactone ring forms of HCPT and their antitumor activities.
    Zhou JJ; Liu J; Xu B
    Acta Pharmacol Sin; 2001 Sep; 22(9):827-30. PubMed ID: 11749865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-beta-cyclodextrin inoculations.
    Xie C; Li X; Luo X; Yang Y; Cui W; Zou J; Zhou S
    Int J Pharm; 2010 May; 391(1-2):55-64. PubMed ID: 20170717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].
    Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS
    Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.